CFOO China Foods Holdings Ltd.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1310630 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-46.6%
TTM net income YoY33.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—
Margins
Gross margin7.9%
Operating margin-173.9%
Net margin-173.8%
FCF margin—
EBITDA margin-170.1%
Returns
ROE—
ROA-114.1%
ROIC (approx.)—
Asset turnover0.66x
Leverage & solvency
Liabilities / assets756.1%
Debt / equity—
Current ratio0.11x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.09x
Accruals ratio10.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $327,871 | $233,339 |
| Cost of revenue | $297,909 | $179,466 |
| Gross profit | $29,962 | $53,873 |
| SG&A expense | $423,644 | $502,654 |
| Operating income | -$398,923 | -$455,637 |
| Pretax income | -$398,672 | -$454,735 |
| Income tax | — | $836 |
| Net income | -$398,672 | -$455,571 |
| EBITDA | -$391,934 | -$453,869 |
| EPS (basic) | -0.02 | -0.02 |
| EPS (diluted) | -0.02 | -0.02 |
| Weighted avg. shares (diluted) | 20.25M | 20.25M |
| Banking | ||
| Net interest income | $45 | $329 |
| Balance sheet | ||
| Cash & equivalents | $9,893 | $39,192 |
| Inventory | $39,255 | $54,943 |
| Current assets | $162,943 | $398,686 |
| PP&E, net | $27,860 | $34,264 |
| Intangibles | $1,662 | $2,055 |
| Total assets | $212,890 | $435,005 |
| Current liabilities | $1.48M | $1.29M |
| Total liabilities | $1.49M | $1.29M |
| Shareholders' equity | -$1.28M | -$850,807 |
| Shares outstanding | 20.25M | 20.25M |
| Cash flow statement | ||
| Operating cash flow | -$389,251 | -$353,812 |
| Capital expenditure | — | $23,454 |
| Free cash flow | — | -$377,266 |
| Investing cash flow | — | -$23,454 |
| Financing cash flow | $388,605 | $245,524 |
| Depreciation & amortization | $6,989 | $1,768 |
Free plan shows the latest 2 periods; Pro shows all 23 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.